[p-(N'-Methylene-hydrazinomethyl)-N-isopropylbenzamide (methylhydrazine) in the treatment of systemic non-leukemic lymphatic diseases].
作者信息
Grignani F, Mastrodicasa M, Colonna A, Tonato M, Martelli M
出版信息
Clin Ter. 1966 May 31;37(4):325-41.
PMID:5926019
Abstract
摘要
相似文献
1
2
3
[On the effect of a cytostatic of the methylhydrazine group on malignant hemoblastomas].[关于甲基肼类细胞抑制剂对恶性成血细胞肿瘤的作用]
Wien Med Wochenschr. 1966 May 21;116(21):468-71.
4
[Chemotherapy of malignant systemic diseases with a methylhydrazine derivative, Natulan].
Ugeskr Laeger. 1967 Nov 2;129(44):1472-6.
5
6
[Hodgkin's disease and hematosarcomas. Treatment trial by 2 methylhydrazines].[霍奇金病与血液肉瘤。2-甲基肼治疗试验]
Concours Med. 1965 Jul 3;87(27):4555-62.
7
Clinical experience with ibenzmethyzin (Natulan) in the treatment of lymphomas and solid tumours.
Ann Med Intern Fenn. 1967;56(3):119-24.
8
[A new methylhydrazine derivative (Ro 4-6467 or Natulan) in the treatment of Hodgkin's disease. Study of 10 cases].
Rev Bras Med. 1966 Jul;23(7):483-9.
9
[Cytostatic therapy of malignant lymphoma].[恶性淋巴瘤的细胞抑制疗法]
Wien Klin Wochenschr. 1971 Jul 9;83(27):516-22.
10
[First clinical experiences with methylhydrazine in treatment of malignant lymphogranuloma].[甲基肼治疗恶性淋巴肉芽肿的首次临床经验]
Minerva Med. 1965 Dec 12;56(99):4338-43.
Zotero 插件